|
1
|
Monte I, Bottari VE, Buccheri S, Blundo A,
Sirugo L, Leggio S and Licciardi S: Chemotherapy-induced
cardiotoxicity: Subclinical cardiac dysfunction evidence using
speckle tracking echocardiography. J Cardiovasc Echogr. 23:33–38.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao J, Ge MH and Ling ZQ: Fbxw7 tumor
suppressor: A vital regulator contributes to human tumorigenesis.
Medicine (Baltimore). 95:e24962016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Wang Z, Zhang W, Qian K, Xu W and
Zhang S: Fbxw7 regulates tumor apoptosis, growth arrest and the
epithelial-to-mesenchymal transition in part through the RhoA
signaling pathway in gastric cancer. Cancer Lett. 370:39–55. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma X, Cai S, Deng C, Jia Y, Khan S and
Zhao L: Expression of FBXW7 in esophageal cancer tissues and its
effects on cell proliferation and cell cycle. J Shanxi Med Univ.
53:655–662. 2022.(In Chinese).
|
|
5
|
Lu P and Cheng X: Expression and clinical
significance of FBXW7 and fam83d in endometrioid adenocarcinoma. J
Clin Exp Pathol. 38:564–568. 2022.(In Chinese).
|
|
6
|
Zhang L, Chen C, Yu YB, Li Y, Hui S and Li
F: Expression and diagnostic value of Calreticulin, VRK1, FBXW7 in
diffuse large B-cell lymphoma. Chin Lab Diagn. 26:276–280. 2022.(In
Chinese).
|
|
7
|
Liu XY, Cui YN, Li J, Zhang Z and Guo RH:
Effect of FBXW7 gene mutation on the prognosis of immunotherapy in
patients with non-small cell lung cancer. Zhonghua Yi Xue Za Zhi.
102:914–921. 2022.(In Chinese). PubMed/NCBI
|
|
8
|
Xu Y, Sengupta T, Kukreja L and Minella
AC: MicroRNA-223 regulates cyclin E activity by modulating
expression of F-box and WD-40 domain protein 7. J Biol Chem.
285:34439–34446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moher D, Liberati A, Tetzlaff J, Altman
DG, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, Clark J,
et al: Preferred reporting items for systematic reviews and
meta-analyses: The PRISMA statement. Rev Esp Nutr Hum Diet.
18:172–181. 2014.(In Spanish). View Article : Google Scholar
|
|
10
|
Wells GA: The Newcastle-Ottawa Scale (NOS)
for Assessing the Quality of Non-Randomised Studies in
Meta-Analyses. Symposium on Systematic Reviews: Beyond the Basics.
2014.
|
|
11
|
Huang GQ, Li H, Zhang CQ, Wu QF and Sun
JH: Expression and clinical significance of CDC4 and c-Myc in
gastric cancer. Chin J Cancer. 25:72015.(In Chinese).
|
|
12
|
Zhang Q, Wang GJ, Pei YX, Li XF and Ni JF:
Expression and clinical significance of FBXW7 and SRC-3 in gastric
cancer. J Shandong Univ (Med Ed). 49:42011.(In Chinese).
|
|
13
|
Huang GQ, Zhang CQ, Peng XC, Zhang N and
Tang WX: The expression and significance of CDC4 and cyclinE in
gastric cancer. Life Sci Res. 15:339–344. 2011.(In Chinese).
|
|
14
|
Li XL, Wang GJ, Pei YX, Zhang Q and Wang
XF: Expression of F-box/WD-40 domain protein 7 and Cyclin E protein
in gastric cancer tissues. J Zhengzhou Univ (Med Ed). 47:494–496.
2012.(In Chinese).
|
|
15
|
Calcagno DQ, Freitas VM, Leal MF, de Souza
CR, Demachki S, Montenegro R, Assumpção PP, Khayat AS, Smith Mde A,
dos Santos AK and Burbano RR: MYC, FBXW7 and TP53 copy number
variation and expression in gastric cancer. BMC Gastroenterol.
13:1412013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li MR, Zhu CC, Ling TL, Zhang YQ, Xu J,
Zhao EH and Zhao G: FBXW7 expression is associated with prognosis
and chemotherapeutic outcome in Chinese patients with gastric
adenocarcinoma. BMC Gastroenterol. 17:602017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Jin W, Jia H, Yan J and Zhang G:
MiR-223 promotes the cisplatin resistance of human gastric cancer
cells via regulating cell cycle by targeting FBXW7. J Exp Clin
Cancer Res. 34:282015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eto K, Iwatsuki M, Watanabe M, Ishimoto T,
Ida S, Imamura Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, et al:
The sensitivity of gastric cancer to trastuzumab is regulated by
the miR-223/FBXW7 pathway. Int J Cancer. 136:1537–1545. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sancho R, Gruber R, Gu G and Behrens A:
Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ,
and β cells. Cell Stem Cell. 15:139–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bredel M, Bredel C, Juric D, Harsh GR,
Vogel H, Recht LD and Sikic BI: Functional network analysis reveals
extended gliomagenesis pathway maps and three novel MYC-interacting
genes in human gliomas. Cancer Res. 65:8679–8689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu Z, Inomata K, Ishizawa K and Horii A:
The FBXW7 beta-form is suppressed in human glioma cells. Biochem
Biophys Res Commun. 354:992–998. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Milne AN, Leguit R, Corver WE, Morsink HM,
Polak M, de Leng WW, Carvalho R and Offerhaus GJA: Loss of
CDC4/FBXW7 in gastric carinoma. Anal Cell Pathol. 32:4037962010.
View Article : Google Scholar
|
|
23
|
Yokobori T, Mimori K, Iwatsuki M, Ishii H,
Onoyama I, Fukagawa T, Kuwano H, Nakayama KI and Mori M:
p53-Altered FBXW7 expression determines poor prognosis in gastric
cancer cases. Cancer Res. 69:3788–3794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akhoondi S, Sun D, von der Lehr N,
Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D,
Marth C, et al: FBXW7/hCDC4 is a general tumor suppressor in human
cancer. Cancer Res. 67:9006–9012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng HH, Yang Z, Qiu YB, Bashir S, Li Y
and Xu M: Detection of a novel panel of 24 genes with high
frequencies of mutation in gastric cancer based on next-generation
sequencing. World J Clin Cases. 10:4761–4775. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo J, Chen J, Li H, Yang Y, Yun H, Yang S
and Mao X: LncRNA UCA1 promotes the invasion and EMT of bladder
cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett.
14:5556–5562. 2017.PubMed/NCBI
|
|
27
|
Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G,
Zhao Q, Wu D, Gong W, Du M, et al: LncRNA MT1JP functions as a
ceRNA in regulating FBXW7 through competitively binding to
miR-92a-3p in gastric cancer. Mol Cancer. 17:872018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hou J, Liu Y, Yan D, Huang P, Wang, Gu H,
Lan C, Geng S and Cui H: MiR-124-3p/ZC3H15 regulates gastric cancer
progression by blocking FBXW7 mediated degradation of c-Myc. Res
Sq. 2020.
|
|
29
|
Deng T, Shen P, Li A, Zhang Z, Yang H,
Deng X, Peng X, Hu Z, Tang Z, Liu J, et al: CCDC65 as a new
potential tumor suppressor induced by metformin inhibits activation
of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics.
11:8112–8128. 2021. View Article : Google Scholar : PubMed/NCBI
|
